98 related articles for article (PubMed ID: 17047343)
1. Leydig-cell tumour in children: variable clinical presentation, diagnostic features, follow-up and genetic analysis of four cases.
Petkovic V; Salemi S; Vassella E; Karamitopoulou-Diamantis E; Meinhardt UJ; Flück CE; Mullis PE
Horm Res; 2007; 67(2):89-95. PubMed ID: 17047343
[TBL] [Abstract][Full Text] [Related]
2. Absence of activating mutations in the hot spots of the LH receptor and Gs-alpha genes in Leydig cell tumors.
Vieira TC; Cerutti JM; Dias da Silva MR; Delcelo R; Abucham J
J Endocrinol Invest; 2002; 25(7):598-602. PubMed ID: 12150333
[TBL] [Abstract][Full Text] [Related]
3. Activating point mutations in cyclin-dependent kinase 4 are not seen in sporadic pituitary adenomas, insulinomas or Leydig cell tumours.
Vax VV; Bibi R; Diaz-Cano S; Gueorguiev M; Kola B; Borboli N; Bressac-de Paillerets B; Walker GJ; Dedov II; Grossman AB; Korbonits M
J Endocrinol; 2003 Aug; 178(2):301-10. PubMed ID: 12904177
[TBL] [Abstract][Full Text] [Related]
4. Atypical presentation of Leydig cell tumour in three prepubertal patients: diagnosis, treatment and outcomes.
García González M; Casal-Beloy I; Somoza Argibay I; Dargallo Carbonell T
J Pediatr Endocrinol Metab; 2019 Apr; 32(4):369-374. PubMed ID: 30875329
[TBL] [Abstract][Full Text] [Related]
5. Cellular proliferation and nuclear ploidy assessments augment established prognostic factors in predicting malignancy in testicular Leydig cell tumours.
McCluggage WG; Shanks JH; Arthur K; Banerjee SS
Histopathology; 1998 Oct; 33(4):361-8. PubMed ID: 9822927
[TBL] [Abstract][Full Text] [Related]
6. Mutational analysis of the luteinizing hormone receptor gene in two individuals with Leydig cell tumors.
Canto P; Söderlund D; Ramón G; Nishimura E; Méndez JP
Am J Med Genet; 2002 Mar; 108(2):148-52. PubMed ID: 11857565
[TBL] [Abstract][Full Text] [Related]
7. Testis sparing enucleation of a Leydig-cell tumour in a boy.
Merlini E; Seymandi PL; Betta PG; Bussi G
Pediatr Med Chir; 2003; 25(1):63-5. PubMed ID: 12920981
[TBL] [Abstract][Full Text] [Related]
8. Switch of cadherin expression as a diagnostic tool for Leydig cell tumours.
Bremmer F; Schweyer S; Martin-Ortega M; Hammerlein B; Strauss A; Radzun HJ; Behnes CL
APMIS; 2013 Oct; 121(10):976-81. PubMed ID: 23398382
[TBL] [Abstract][Full Text] [Related]
9. Peripheral precocious puberty in a male caused by Leydig cell adenoma harboring a somatic mutation of the LHR gene: report of a case.
Sangkhathat S; Kanngurn S; Jaruratanasirikul S; Tubtawee T; Chaiyapan W; Patrapinyokul S; Chiengkriwate P
J Med Assoc Thai; 2010 Sep; 93(9):1093-7. PubMed ID: 20873084
[TBL] [Abstract][Full Text] [Related]
10. Activating mutation of the stimulatory G protein (gsp) as a putative cause of ovarian and testicular human stromal Leydig cell tumors.
Fragoso MC; Latronico AC; Carvalho FM; Zerbini MC; Marcondes JA; Araujo LM; Lando VS; Frazzatto ET; Mendonca BB; Villares SM
J Clin Endocrinol Metab; 1998 Jun; 83(6):2074-8. PubMed ID: 9626141
[TBL] [Abstract][Full Text] [Related]
11. Leydig-cell tumors caused by an activating mutation of the gene encoding the luteinizing hormone receptor.
Liu G; Duranteau L; Carel JC; Monroe J; Doyle DA; Shenker A
N Engl J Med; 1999 Dec; 341(23):1731-6. PubMed ID: 10580072
[No Abstract] [Full Text] [Related]
12. Unusual hyperechoic ultrasound appearance of testicular Leydig cell tumour.
Avery GR; Peakman DJ; Young JR
Clin Radiol; 1991 Apr; 43(4):260-1. PubMed ID: 2025998
[TBL] [Abstract][Full Text] [Related]
13. Leydig cell tumour: enucleation as a therapeutic choice in a case with atypical symptoms.
García M; Dargallo T; Palacios M; Carames J; Gómez J; Sacristán F; Vela D
Arch Esp Urol; 2012 Dec; 65(10):897-9. PubMed ID: 23269338
[TBL] [Abstract][Full Text] [Related]
14. Surgery in infants and children with testicular and paratesticular tumours: a single centre experience over a 25-year-period.
Tröbs RB; Krauss M; Geyer C; Tannapfel A; Körholz D; Hirsch W
Klin Padiatr; 2007; 219(3):146-51. PubMed ID: 17525908
[TBL] [Abstract][Full Text] [Related]
15. Leydig cell tumors in children: contrasting clinical, hormonal, anatomical, and molecular characteristics in boys and girls.
Olivier P; Simoneau-Roy J; Francoeur D; Sartelet H; Parma J; Vassart G; Van Vliet G
J Pediatr; 2012 Dec; 161(6):1147-52. PubMed ID: 22727875
[TBL] [Abstract][Full Text] [Related]
16. Male LH-independent sexual precocity in a 3.5-year-old boy caused by a somatic activating mutation of the LH receptor in a Leydig cell tumor.
Richter-Unruh A; Wessels HT; Menken U; Bergmann M; Schmittmann-Ohters K; Schaper J; Tappeser S; Hauffa BP
J Clin Endocrinol Metab; 2002 Mar; 87(3):1052-6. PubMed ID: 11889161
[TBL] [Abstract][Full Text] [Related]
17. Origin and evolution of somatic cell testicular tumours in transgenic mice.
Quintana S; Venara M; Rey R; di Clemente N; Chemes HE
J Pathol; 2010 Aug; 221(4):443-51. PubMed ID: 20593483
[TBL] [Abstract][Full Text] [Related]
18. [Malignant Leydig cell tumor of the testis secreting progesterone].
Daniel L; Lechevallier E; Liprandi A; de Fromont M; Pellissier JF; Coulange C
Prog Urol; 1998 Dec; 8(6):1047-50. PubMed ID: 9894267
[TBL] [Abstract][Full Text] [Related]
19. [The Leydig-cell testicular tumor. A case report with magnetic resonance images].
Tamayo Ruiz JC; Rodríguez de Bethencourt F; Hontoria Briso JM; Sánchez Chapado M; Martínez Fernández V; Viaño J
Arch Esp Urol; 1998 Nov; 51(9):928-31. PubMed ID: 9887568
[TBL] [Abstract][Full Text] [Related]
20. Multiparametric ultrasound for the diagnosis of Leydig cell tumours in non-palpable testicular lesions.
Corcioni B; Brandi N; Marasco G; Gaudiano C; De Cinque A; Ciccarese F; Ercolino A; Schiavina R; Brunocilla E; Renzulli M; Golfieri R
Andrology; 2022 Oct; 10(7):1387-1397. PubMed ID: 35842907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
